EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive
Recent news

Value in Health, Volume 17, Issue 4, Pages 471-475, June 2014
Authors:C. Daniel Mullins, PhD; Joseph Vandigo, MBA; Zhiyuan Zheng, PhD; Paul Wicks, PhD

To view the article, please click here.







Recent news

» MPE Publishes 2021: Year in Review

» ASH 2021| over 50% of myeloma patients reach minimal residual disease negativity with Isatuximab in combination with RVd

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy